ANTX

AN2 TherapeuticsA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

RSI (14)

42.3

Neutral

MACD Hist

-0.10

Bearish

ATR (14)

0.44

Normal

Vol Z (20)

-0.39

Normal

RET 20D

-13.2%

Negative

Dist 52W High

-25.5%

Below High

Technical chart

1 Year

Candles, moving averages, and volume using the current RankAlpha theme.

As of 2026-06-02

Price

SMA 20

SMA 50

SMA 200

Trend readout

Technical readout

Trend

Uptrend (SMA20 > SMA50 > SMA200)

Momentum

Negative momentum · 20D -13.2% · 60D -22.5%

RSI / MACD

RSI 42.3 (Neutral) · MACD hist -0.10

Volatility

Volatility normal (Z -0.39)

SMA20

4.54

SMA50

4.07

SMA200

2.09

EMA12

4.45

EMA26

4.39

BB Upper

4.97

BB Mid

4.54

BB Lower

4.12

RET 5D

-12.1%

RET 20D

-13.2%

RET 60D

-22.5%

RET 120D

+253.9%

As of 2026-06-02 • Updated nightlySource: Internal modelMethodology